Dear AuntMinnie Europe member,
The annual congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) gets underway in Copenhagen on Saturday. What awaits the more than 7,000 participants set to attend CIRSE 2026? Click here for our preview.
In other news, a group from Erasmus Medical Center found that AI software pulmonary nodule assessment was able to reduce reporting times by almost 15%. Get all of the details here.
What are the most important recent developments in theranostics? Associate Editor Claudia Tschabuschnig recently spoke with Prof. Ken Hermann, of University Hospital Essen, for an update and to hear about the work still required to make theranostics a central component of cancer care. Learn more in our Q&A article and also our video interview.
Another popular story this week featured new research that used MRI to demonstrate how ovarian hormones can influence parts of the brain involved in emotion control.
Please see below for our full list of top stories from the week.
Erik L. Ridley
Editor in Chief
AuntMinnieEurope.com
1. What to watch for at CIRSE 2026
2. AI cuts chest reporting time
3. Q&A with Ken Hermann: Theranostics must move earlier and beyond established targets
4. Video: Ken Harmann maps nuclear medicine’s next frontiers
5. MRI shows how hormones affect mood
6. Swiss nuclear medicine seeks rules fit for radiopharmaceutical innovation
7. GEHC’s Photonova Spectra photon-counting CT receives CE Mark
8. Bayer’s PET agent meets endpoints in phase III cardiac amyloidosis study
9. GEHC adds three systems to Vivid ultrasound portfolio
10. BIR signs three-year collaboration agreement with IAEA